Literature DB >> 21794859

Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer.

Tsuyoshi Hamada1, Hiroyuki Isayama, Yousuke Nakai, Osamu Togawa, Hirofumi Kogure, Kazumichi Kawakubo, Takeshi Tsujino, Naoki Sasahira, Kenji Hirano, Natsuyo Yamamoto, Toshihiko Arizumi, Yukiko Ito, Saburo Matsubara, Takashi Sasaki, Hiroshi Yagioka, Yoko Yashima, Dai Mohri, Kohji Miyabayashi, Suguru Mizuno, Rie Nagano, Naminatsu Takahara, Nobuo Toda, Minoru Tada, Masao Omata, Kazuhiko Koike.   

Abstract

BACKGROUND: Although the placement of self-expandable metal stents (SEMSs) has been widely accepted as palliation for distal malignant biliary obstruction, the risk factors for their early dysfunction remain unclear.
OBJECTIVE: To identify risk factors for early (<3 months) SEMS dysfunction in unresectable pancreatic cancer.
DESIGN: A multicenter retrospective study.
SETTING: Five tertiary referral centers. PATIENTS: Patients were included who underwent first-time SEMS placement for distal malignant biliary obstruction caused by pancreatic cancer between April 1994 and August 2010. MAIN OUTCOME MEASUREMENTS: Rates and causes of early dysfunction were evaluated, and risk factors were analyzed.
RESULTS: In all, 317 eligible patients were identified. Covered SEMSs were placed in 82% of patients. Duodenal invasion was observed endoscopically in 37%. The median time to dysfunction was 170 days. The rates of all and early SEMS dysfunction were 55% and 31%, respectively. The major causes of SEMS dysfunction were food impaction and nonocclusion cholangitis (21% each) in early dysfunction and sludge (29%) in nonearly dysfunction. The rate of early dysfunction was 42% with duodenal invasion and 24% without duodenal invasion (P = .001). Early dysfunction caused by food impaction was more frequent in patients with duodenal invasion (10% and 4%, P = .053). Duodenal invasion was a risk factor (odds ratio 2.35; 95% CI, 1.43-3.90; P = .001) in a multiple logistic regression model. LIMITATIONS: A retrospective design.
CONCLUSIONS: Duodenal invasion is a risk factor for early SEMS dysfunction in patients with pancreatic cancer.
Copyright © 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21794859     DOI: 10.1016/j.gie.2011.04.046

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  21 in total

1.  Application of chemokine receptor antagonist with stents reduces local inflammation and suppresses cancer growth.

Authors:  Ai-Wu Mao; Ting-Hui Jiang; Xian-Jun Sun; Jian Peng
Journal:  Tumour Biol       Date:  2015-06-05

2.  Endoscopic bilio-duodenal bypass: outcomes of primary and revision efficacy of combined metallic stents in malignant duodenal and biliary obstructions.

Authors:  Jorge Canena; João Coimbra; Diana Carvalho; Catarina Rodrigues; Mário Silva; Mariana Costa; David Horta; António Mateus Dias; Isabel Seves; Gonçalo Ramos; Leonel Ricardo; António Pereira Coutinho; Carlos Romão; Pedro Mota Veiga
Journal:  Dig Dis Sci       Date:  2014-05-13       Impact factor: 3.199

Review 3.  Advances in stent therapy for malignant biliary obstruction.

Authors:  Xin He; Ying Zhu; Yining Wang; Yuanzhen Hao; Junbo Hong
Journal:  Abdom Radiol (NY)       Date:  2021-01

4.  Percutaneous transpapillary biliary stent placement for distal malignant biliary obstruction: Outcomes and survival analysis.

Authors:  Qing-Quan Zu; Jin-Xing Zhang; Bin Wang; Wei Ye; Sheng Liu; Hai-Bin Shi
Journal:  Turk J Gastroenterol       Date:  2019-08       Impact factor: 1.852

5.  Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariate.

Authors:  Tsuyoshi Hamada; Yousuke Nakai; Hiroyuki Isayama; Takashi Sasaki; Hirofumi Kogure; Kazumichi Kawakubo; Naoki Sasahira; Natsuyo Yamamoto; Osamu Togawa; Suguru Mizuno; Yukiko Ito; Kenji Hirano; Nobuo Toda; Minoru Tada; Kazuhiko Koike
Journal:  Surg Endosc       Date:  2012-10-17       Impact factor: 4.584

6.  A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy.

Authors:  Hiroshi Yamauchi; Mitsuhiro Kida; Kosuke Okuwaki; Shiro Miyazawa; Tomohisa Iwai; Hiroshi Imaizumi; Miyata Eiji; Rikiya Hasegawa; Wasaburo Koizumi
Journal:  Dig Dis Sci       Date:  2016-03-31       Impact factor: 3.199

Review 7.  Palliative Percutaneous Biliary Interventions in Malignant High Bile Duct Obstruction.

Authors:  Amy R Deipolyi; Anne M Covey
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

8.  Transmural biliary drainage can be an alternative to transpapillary drainage in patients with an indwelling duodenal stent.

Authors:  Tsuyoshi Hamada; Hiroyuki Isayama; Yousuke Nakai; Hirofumi Kogure; Natsuyo Yamamoto; Kazumichi Kawakubo; Naminatsu Takahara; Rie Uchino; Suguru Mizuno; Takashi Sasaki; Osamu Togawa; Saburo Matsubara; Yukiko Ito; Kenji Hirano; Takeshi Tsujino; Minoru Tada; Kazuhiko Koike
Journal:  Dig Dis Sci       Date:  2014-05-20       Impact factor: 3.199

9.  Multicenter study of endoscopic preoperative biliary drainage for malignant distal biliary obstruction.

Authors:  Naoki Sasahira; Tsuyoshi Hamada; Osamu Togawa; Ryuichi Yamamoto; Tomohisa Iwai; Kiichi Tamada; Yoshiaki Kawaguchi; Kenji Shimura; Takero Koike; Yu Yoshida; Kazuya Sugimori; Shomei Ryozawa; Toshiharu Kakimoto; Ko Nishikawa; Katsuya Kitamura; Tsunao Imamura; Masafumi Mizuide; Nobuo Toda; Iruru Maetani; Yuji Sakai; Takao Itoi; Masatsugu Nagahama; Yousuke Nakai; Hiroyuki Isayama
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

10.  A Novel Partially Covered Self-Expandable Metallic Stent with Proximal Flare in Patients with Malignant Gastric Outlet Obstruction.

Authors:  Naminatsu Takahara; Hiroyuki Isayama; Yousuke Nakai; Shuntaro Yoshida; Tomotaka Saito; Suguru Mizuno; Hiroshi Yagioka; Hirofumi Kogure; Osamu Togawa; Saburo Matsubara; Yukiko Ito; Natsuyo Yamamoto; Minoru Tada; Kazuhiko Koike
Journal:  Gut Liver       Date:  2017-07-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.